Search
Home
>
Clinical Trials
>
Treatment Trials
> Melanoma
Melanoma
Click
on the protocol number to learn more about that clinical trial.
CTSU ECOG E1609
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma
/Melanoma.aspx
Categories
Subscribe
Quick Links
Brain Cancer
Breast Cancer
Gastrointestinal Cancers
Genitourinary Cancer
Gynecologic Cancer
Head and Neck Cancer
Hematology
Lung Cancer
Melanoma
Unknown Primary
|
Login
|
Print this page
© OzarksCancerResearch.org - All Right Reserved. | Powered by
Winnovate
w360™
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon Alfa-2b for Resected High-Risk Melanoma